Biosecurity And Dual-Use Research Control

1. Introduction

Biosecurity and dual-use research control are important components of modern biotechnology governance. Biosecurity refers to the legal, institutional, and technical measures adopted to prevent the unauthorised access, misuse, theft, diversion, release, or deliberate harmful application of biological materials, pathogens, toxins, and related scientific technologies.

Dual-use research refers to scientific research that has legitimate beneficial applications but may also create risks if its findings, materials, techniques, or technologies are misused. For example, research involving infectious microorganisms may contribute to vaccine development, disease prevention, and medical treatment, but the same knowledge may potentially be exploited to increase pathogenicity, transmissibility, or resistance to existing treatments.

The regulation of dual-use research attempts to maintain a balance between scientific freedom, public health, national security, ethical responsibility, and international cooperation.

In biotechnology law, this subject is particularly significant because advances in synthetic biology, genetic engineering, gene editing, and artificial intelligence have increased the accessibility and potential consequences of biological research.

2. Meaning and Scope of Dual-Use Research

Dual-use research generally involves scientific activities that may produce both beneficial and harmful outcomes.

Examples include:

Genetic modification of microorganisms for pharmaceutical production.

Research involving dangerous pathogens for vaccine development.

Synthetic biology experiments involving engineered organisms.

Development of antimicrobial resistance detection technologies.

Genetic sequencing and modification of infectious agents.

Research involving toxins and biologically active substances.

Development of technologies capable of modifying biological characteristics.

A particularly important category is Dual-Use Research of Concern (DURC). It refers to research that, based on its methodology and reasonably anticipated outcomes, could provide knowledge, products, or technologies that may be misapplied to create significant threats to public health, agriculture, animals, or national security.

Therefore, dual-use governance requires risk assessment before, during, and after research activities.

3. Legal Framework Governing Biosecurity

A. Biological Weapons Convention, 1972

The Biological Weapons Convention (BWC) is the principal international treaty prohibiting the development, production, acquisition, and stockpiling of biological and toxin weapons.

Article I prohibits biological agents and toxins of types and quantities that have no justification for prophylactic, protective, or other peaceful purposes.

Article IV requires states to adopt necessary national measures to prohibit and prevent prohibited activities within their jurisdiction.

The Convention is particularly relevant to dual-use research because it distinguishes legitimate scientific research from activities intended for hostile purposes.

B. Convention on Biological Diversity, 1992

The Convention on Biological Diversity establishes international obligations concerning biodiversity conservation, sustainable use, and fair benefit-sharing.

Its biosafety framework is relevant to the movement and environmental release of living modified organisms.

C. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol regulates the safe handling, transport, and use of living modified organisms resulting from modern biotechnology.

It adopts the precautionary approach and provides procedures for assessing potential risks associated with certain transboundary movements of living modified organisms.

D. Indian Legal Framework

India regulates biosecurity through several legislative and administrative instruments:

Environment (Protection) Act, 1986: Provides the legal foundation for regulating genetically engineered organisms and hazardous biological activities.

Rules, 1989: Regulate the manufacture, use, import, export, and storage of hazardous microorganisms and genetically engineered organisms.

Biological Diversity Act, 2002: Regulates access to biological resources and associated traditional knowledge.

Foreign Trade (Development and Regulation) Act, 1992: Supports restrictions and controls on specified exports.

Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005: Prohibits specified unlawful activities involving biological weapons and related materials.

Disaster Management Act, 2005: Provides institutional mechanisms for managing biological emergencies and disasters.

Together, these instruments establish an important foundation for preventing biological misuse.

4. Institutional Mechanisms for Dual-Use Research Control

Effective biosecurity governance requires institutional supervision throughout the research process.

A. Institutional Biosafety Committees (IBSCs)

IBSCs examine research involving genetically engineered organisms and hazardous biological materials. They assess laboratory safety, containment arrangements, personnel responsibilities, and compliance with applicable regulations.

B. Review by National Authorities

In India, the Genetic Engineering Appraisal Committee (GEAC), functioning under the Ministry of Environment, Forest and Climate Change, performs regulatory functions concerning specified activities involving genetically engineered organisms.

C. Research Risk Assessment

Research institutions should evaluate:

The potential harmful applications of research findings.

Risks associated with biological materials and technologies.

The possibility of accidental release or unauthorised access.

Whether additional regulatory approval is necessary.

Appropriate safeguards for research information.

D. Research Publication Controls

Scientific journals and research institutions may undertake additional review before publishing sensitive research findings. Publication decisions should consider public-health benefits, scientific openness, and potential misuse.

E. Export and Technology Transfer Controls

The transfer of biological materials, equipment, technical information, and controlled technologies may require government authorisation. These restrictions help prevent biological technologies from reaching prohibited military or terrorist applications.

5. Important Judicial Decisions and Case Laws

Although there are relatively few reported judicial decisions directly addressing dual-use research of concern, several important cases establish principles relevant to biosecurity, scientific regulation, and biological risk management.

A. Gene Campaign v. Union of India (2024 INSC 545)

The Supreme Court examined regulatory procedures concerning genetically modified mustard and the approval granted by the environmental regulatory authorities.

The judgment addressed scientific risk assessment, regulatory transparency, environmental protection, and the role of expert institutions in biotechnology governance. The Court delivered a split verdict, with both judges agreeing that the approval process required further attention, although they differed on aspects of the appropriate relief.

Legal significance: The decision demonstrates that biotechnology approvals must be supported by scientific evaluation, transparency, and appropriate regulatory safeguards. These principles are relevant to the assessment of dual-use biological research.

VoxJuris+1

B. Aruna Rodrigues v. Union of India (2012 onwards)

This litigation concerned the environmental and biosafety implications of genetically modified crops.

The Supreme Court considered issues relating to regulatory supervision, scientific assessment, and the responsibilities of authorities under the Environment (Protection) Act, 1986 and the 1989 Rules.

Legal significance: The proceedings highlight the importance of independent scientific scrutiny, institutional accountability, and effective monitoring of potentially hazardous biological technologies.

Supreme Court

C. LibertyWorks Inc v. Commonwealth of Australia [2021] FCA 1433

The Federal Court of Australia considered challenges relating to international travel restrictions imposed under the Biosecurity Act 2015 during the COVID-19 emergency.

Legal significance: Although the case concerned public-health emergency measures rather than dual-use laboratory research, it illustrates the legal importance of statutory authority and the government's responsibility to address serious biological threats.

International Bar Association

D. United States v. Progressive, Inc. 467 F. Supp. 990 (W.D. Wis. 1979)

The case concerned the proposed publication of information relating to hydrogen-bomb design. The United States government sought an injunction on national-security grounds.

Legal significance: Although it involved nuclear rather than biological technology, the case illustrates the tension between scientific publication, freedom of expression, and national security. Similar considerations arise when evaluating whether sensitive dual-use biological research should be published without restrictions.

Law Gratis

6. Ethical and Human Rights Considerations

Biosecurity regulation must not unnecessarily restrict legitimate scientific activities.

Important ethical considerations include:

Scientific freedom: Researchers should retain reasonable freedom to investigate scientific questions.

Public safety: Research must not expose populations to unjustifiable biological risks.

Privacy: Sensitive genetic and biological information must be appropriately protected.

Research accountability: Scientists and institutions must accept responsibility for foreseeable misuse.

Transparency: Regulatory decisions should be supported by understandable scientific reasoning.

Proportionality: Restrictions must be proportionate to the risks involved.

A proper legal framework should avoid both excessive restrictions and inadequate supervision.

7. Challenges in Biosecurity Enforcement

Several challenges complicate the regulation of dual-use research:

Rapid developments in synthetic biology and genetic engineering.

Increasing accessibility of advanced biotechnology.

Difficulty identifying research with potentially harmful applications.

International differences in biosecurity legislation.

Insufficient institutional expertise and regulatory resources.

Risks associated with unauthorised biological-material transfers.

Difficulty monitoring privately funded and internationally collaborative research.

Potential misuse of artificial intelligence in biological research.

The World Health Organization's 2022 Global Guidance Framework for the Responsible Use of the Life Sciences emphasises institutional oversight, risk assessment, education, accountability, and international cooperation as important elements of responsible research governance.

Iris+1

8. Recommendations for Strengthening the Legal Framework

India can strengthen biosecurity and dual-use research governance through the following measures:

Establish a comprehensive national framework specifically addressing dual-use biological research.

Introduce systematic DURC screening for high-risk research projects.

Strengthen institutional biosafety committees and independent regulatory supervision.

Improve coordination between scientific institutions, security agencies, and public-health authorities.

Develop clear rules for the responsible publication of sensitive research findings.

Strengthen monitoring of international transfers of controlled biological materials and technologies.

Introduce mandatory biosecurity education and professional codes of conduct.

Establish appropriate accountability mechanisms for regulatory violations.

9. Conclusion

Biosecurity and dual-use research control are essential for ensuring that biotechnology advances serve peaceful, scientific, medical, and environmental objectives rather than creating threats to society.

The Biological Weapons Convention, Environment (Protection) Act, 1986, Rules, 1989, and Weapons of Mass Destruction and their Delivery Systems (Prohibition of Unlawful Activities) Act, 2005 provide important legal foundations for controlling biological risks in India.

Judicial decisions such as Gene Campaign v. Union of India and Aruna Rodrigues v. Union of India demonstrate the importance of scientific scrutiny, regulatory accountability, and environmental protection. International decisions concerning biosecurity emergencies and scientific publication further illustrate the need to balance public safety with individual and institutional freedoms.

Ultimately, an effective biosecurity framework must combine scientific responsibility, preventive regulation, institutional oversight, international cooperation, and proportionate legal enforcement. The objective is not to prevent scientific innovation but to ensure that scientific knowledge and biological technologies are developed and used responsibly for the benefit of humanity.